Enzyme drives cognitive decline in mice, provides new target for Alzheimer's
Researchers identify the PKC-alpha enzyme as a promising therapeutic target in Alzheimer's disease; a mutation that increases its activity led to biochemical, cellular and cognitive impairments in mice. http://dlvr.it/SdbXdD